Heat shock protein 90 as a molecular target for cancer therapeutics

被引：536

作者：

Isaacs, JS ^{[1
]}

Xu, WP ^{[1
]}

Neckers, L ^{[1
]}

机构：

[1] NCI, Ctr Canc Res, Cell & Canc Biol Branch, NIH, Rockville, MD 20850 USA

来源：

CANCER CELL | 2003年 / 3卷 / 03期

关键词：

D O I：

10.1016/S1535-6108(03)00029-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：213 / 217

页数：5

共 40 条

[1]

Baselga J, 1998, CANCER RES, V58, P2825

[2] Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2 [J].

Basso, AD ;

Solit, DB ;

Munster, PN ;

Rosen, N .

ONCOGENE, 2002, 21 (08) :1159-1166

[3] The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy [J].

Blagosklonny, MV ;

Fojo, T ;

Bhalla, KN ;

Kim, JS ;

Trepel, JB ;

Figg, WD ;

Rivera, Y ;

Neckers, LM .

LEUKEMIA, 2001, 15 (10) :1537-1543

[4] The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins [J].

Connell, P ;

Ballinger, CA ;

Jiang, JH ;

Wu, YX ;

Thompson, LJ ;

Höhfeld, J ;

Patterson, C .

NATURE CELL BIOLOGY, 2001, 3 (01) :93-96

[5]

CSERMELY P, 1993, J BIOL CHEM, V268, P1901

[6] MUTATIONS OF THE VHL TUMOR-SUPPRESSOR GENE IN RENAL-CARCINOMA [J].

GNARRA, JR ;

TORY, K ;

WENG, Y ;

SCHMIDT, L ;

WEI, MH ;

LI, H ;

LATIF, F ;

LIU, S ;

CHEN, F ;

DUH, FM ;

LUBENSKY, I ;

DUAN, DR ;

FLORENCE, C ;

POZZATTI, R ;

WALTHER, MM ;

BANDER, NH ;

GROSSMAN, HB ;

BRAUCH, H ;

POMER, S ;

BROOKS, JD ;

ISAACS, WB ;

LERMAN, MI ;

ZBAR, B ;

LINEHAN, WM .

NATURE GENETICS, 1994, 7 (01) :85-90

[7] BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90 [J].

Gorre, ME ;

Ellwood-Yen, K ;

Chiosis, G ;

Rosen, N ;

Sawyers, CL .

BLOOD, 2002, 100 (08) :3041-3044

[8]

Gradin K, 1996, MOL CELL BIOL, V16, P5221

[9] The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation [J].

Grenert, JP ;

Sullivan, WP ;

Fadden, P ;

Haystead, TAJ ;

Clark, J ;

Mimnaugh, E ;

Krutzsch, H ;

Ochel, HJ ;

Schulte, TW ;

Sausville, E ;

Neckers, LM ;

Toft, DO .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23843-23850

[10] The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes [J].

Grenert, JP ;

Johnson, BD ;

Toft, DO .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) :17525-17533

← 1 2 3 4 →